HOME: Start with MiraLAX® — the leading brand for relief of occas

Start patients on MiraLAX^{^{^®}} first: Its triple action hydrates, softens, and promotes gentle peristalsis^{^{^1-3}}

Miralax product bottle with benefits icons

purple doctor person icons - 9 dark purple and 1 light purple showing 9 out of 10 doctors

In a NEW survey of 300 GIs
9 in 10 said that MiraLAX^® is the
OTC laxative they trust most^5,a,b

^aBased on a survey that asked 300 gastroenterologists to rate the important factors in choosing an OTC medication for adults with occasional constipation and how well MiraLAX^® met those needs. HCPs selected from a set of options based on their clinical experience. Survey details and data are available upon request.⁵
^bGIs rated the strength of their agreement with this statement ≥5 on a scale of 1-7.⁵

See the Results

Your patients like these could benefit from starting MiraLAX^® sooner

See Their Stories

MiraLAX^{^®}: One of the most rigorously studied OTC laxatives^⁸

In a review spanning more than two decades of evidence, MiraLAX^® received a stronger recommendation than stool softeners and fiber supplements

Watch to Learn More

MIRA-proven-datavis

MiraLAX^®has a triple mechanism of action^1-3

Efficacy proven in multiple clinical trials^8‑12

Learn More

Patient resources

Access downloadable tools to help support your patients.

Learn More

Click to expand.

References

References: 1. Schiller LR, Emmett M, Santa Ana CA, Fordtran JS. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94(4):933-941. doi:10.1016/0016-5085(88)90550-1 2. Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest. 1989;84(4):1056-1062. doi:10.1172/JCI114267 3. Andrews CN, Storr M. The pathophysiology of chronic constipation. Can J Gastroenterol. 2011;25(SupplB):16B-21B. 4. Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013;144(1):211-217. doi:10.1053/j.gastro.2012.10.029 5. Data on file, Bayer Healthcare. 6. US Food and Drug Administration. NDA 20-698. Approval letter for MiraLAX powder. February 18, 1999. 7. US Food and Drug Administration. NDA 22-015. Approval letter for MiraLAX powder OTC. October 6, 2006. 8. Rao SSC, Brenner DM. Efficacy and safety of over-the-counter therapies for chronic constipation: an updated systematic review. Am J Gastroenterol. 2021;116(6):1156-1181. doi:10.14309/ajg.0000000000001222 9. DiPalma JA, Cleveland MvB, McGowan J, Herrera JL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102:1436-1441. doi:10.1111/j.1572-0241.2007.01199.x 10. Cleveland MvB, Flavin DP, Ruben RA, Epstein RM, Clark GE. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94(5):478-481. 11. DiPalma JA, Cleveland MB, McGowan J, Herrera JL. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085-1090. doi:10.1097/ SMJ.0b013e318157ec8f 12. Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010;(7):CD007570. doi:10.1002/14651858.CD007570.pub2

Start patients on MiraLAX® first: Its triple action hydrates, softens, and promotes gentle peristalsis1-3

In a NEW survey of 300 GIs 9 in 10 said that MiraLAX® is the OTC laxative they trust most5,a,b

Your patients like these could benefit from starting MiraLAX® sooner